These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17378253)

  • 1. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis.
    Rachelefsky GS; Liao Y; Faruqi R
    Ann Allergy Asthma Immunol; 2007 Mar; 98(3):225-38. PubMed ID: 17378253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.
    Buhl R
    Allergy; 2006 May; 61(5):518-26. PubMed ID: 16629778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device.
    Dekhuijzen PNR; Batsiou M; Bjermer L; Bosnic-Anticevich S; Chrystyn H; Papi A; Rodríguez-Roisin R; Fletcher M; Wood L; Cifra A; Soriano JB; Price DB
    Respir Med; 2016 Nov; 120():54-63. PubMed ID: 27817816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroid metered-dose inhalers: how do variations in technique for solutions versus suspensions affect drug distribution?
    Robinson CA; Tsourounis C
    Ann Pharmacother; 2013 Mar; 47(3):416-20. PubMed ID: 23482731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S; Amin AV; Loke YK
    Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids: hazardous effects on voice-an update.
    Gallivan GJ; Gallivan KH; Gallivan HK
    J Voice; 2007 Jan; 21(1):101-11. PubMed ID: 16442776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
    Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
    Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
    Noonan M; Karpel JP; Bensch GW; Ramsdell JW; Webb DR; Nolop KB; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):36-43. PubMed ID: 11206236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute local tolerability of acidic aqueous vehicles delivered via Respimat Soft Mist Inhaler in hyperreactive asthma patients.
    Leclerc V; Lafferre M; Pavia D
    Respiration; 2007; 74(6):691-6. PubMed ID: 17728532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of gargling affects topical adverse symptoms caused by inhaled corticosteroids in females.
    Kajiwara A; Kita A; Saruwatari J; Morita K; Oniki K; Yamamura M; Murase M; Koda H; Hirota S; Ishizuka T; Nakagawa K
    J Asthma; 2014 Mar; 51(2):221-4. PubMed ID: 24147582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
    Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative oral corticosteroid-sparing effect of 7 inhaled corticosteroids in chronic asthma: a meta-analysis.
    Abdullah AK; Khan S
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):74-81. PubMed ID: 18681088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of local oropharyngeal and laryngeal adverse effects from use of single inhaled corticosteroids and long-acting beta-agonists.
    Horita N; To M; Araki K; Haruki K; To Y
    Allergol Int; 2012 Dec; 61(4):583-8. PubMed ID: 22918215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.